Decreased CD8+ T cell response to Epstein-Barr virus infected B cells in multiple sclerosis is not due to decreased HLA class I expression on B cells or monocytes
- PMID: 21810280
- PMCID: PMC3163532
- DOI: 10.1186/1471-2377-11-95
Decreased CD8+ T cell response to Epstein-Barr virus infected B cells in multiple sclerosis is not due to decreased HLA class I expression on B cells or monocytes
Abstract
Background: Patients with multiple sclerosis (MS) have a decreased frequency of CD8+ T cells reactive to their own Epstein-Barr virus (EBV) infected B cells. We have proposed that this might predispose to the development of MS by allowing EBV-infected autoreactive B cells to accumulate in the central nervous system. The decreased CD8+ T cell response to EBV results from a general CD8+ T cell deficiency and also a decreased proportion of EBV-specific T cells within the total CD8+ T cell population. Because decreased HLA class I expression on monocytes and B cells has been reported in MS and could influence the generation and effector function of EBV-specific CD8+ T cells, the present study was undertaken to measure the expression of HLA molecules on B cells and monocytes in patients with MS.
Methods: We used flow cytometry to determine the proportions of T cells, natural killer cells, B cells and monocytes in peripheral blood mononuclear cells (PBMC) and to quantify the expression of HLA molecules on T cells, B cells and monocytes of 59 healthy subjects and 62 patients with MS who had not received corticosteroids or immunomodulatory therapy in the previous 3 months.
Results: The levels of HLA class I and class II molecules expressed on T cells, B cells and monocytes were normal in patients with MS, with the exception of two patients with secondary progressive MS with very low class II expression on B cells. In confirmation of previous studies we also found that the percentage of CD8+ T cells was significantly decreased whereas the percentage of CD4+ T cells and the CD4:CD8 ratio were significantly increased in patients with MS compared to healthy subjects.
Conclusions: The decreased CD8+ T cell response to EBV-infected B cells in MS patients is not due to decreased HLA class I expression on monocytes or B cells. In a small proportion of patients decreased HLA class II expression on B cells might impair the CD8+ T cell response to EBV by reducing CD4+ T cell help.
Similar articles
-
The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis.Front Immunol. 2021 Jul 7;12:665718. doi: 10.3389/fimmu.2021.665718. eCollection 2021. Front Immunol. 2021. PMID: 34305896 Free PMC article. Review.
-
Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.J Virol. 2019 Nov 26;93(24):e00980-19. doi: 10.1128/JVI.00980-19. Print 2019 Dec 15. J Virol. 2019. PMID: 31578295 Free PMC article.
-
Epstein-Barr virus peptide presented by HLA-E is predominantly recognized by CD8(bright) cells in multiple sclerosis patients.PLoS One. 2012;7(9):e46120. doi: 10.1371/journal.pone.0046120. Epub 2012 Sep 25. PLoS One. 2012. PMID: 23049954 Free PMC article.
-
Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis.J Neurol Neurosurg Psychiatry. 2009 May;80(5):498-505. doi: 10.1136/jnnp.2008.161018. Epub 2008 Nov 17. J Neurol Neurosurg Psychiatry. 2009. PMID: 19015225 Free PMC article.
-
Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.Semin Cancer Biol. 2008 Dec;18(6):397-408. doi: 10.1016/j.semcancer.2008.10.008. Epub 2008 Oct 25. Semin Cancer Biol. 2008. PMID: 18977445 Review.
Cited by
-
Epstein-Barr Virus and Multiple Sclerosis.Front Immunol. 2020 Dec 17;11:587078. doi: 10.3389/fimmu.2020.587078. eCollection 2020. Front Immunol. 2020. PMID: 33391262 Free PMC article. Review.
-
Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy.Clin Transl Immunology. 2014 Oct 31;3(10):e27. doi: 10.1038/cti.2014.25. eCollection 2014 Oct. Clin Transl Immunology. 2014. PMID: 25505955 Free PMC article. Review.
-
Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis.Mult Scler. 2014 Dec;20(14):1825-32. doi: 10.1177/1352458514536252. Epub 2014 May 19. Mult Scler. 2014. PMID: 24842963 Free PMC article.
-
The role of the Epstein-Barr virus in the pathogenesis of some autoimmune disorders - Similarities and differences.Eur J Microbiol Immunol (Bp). 2011 Dec;1(4):267-78. doi: 10.1556/EuJMI.1.2011.4.2. Epub 2011 Dec 23. Eur J Microbiol Immunol (Bp). 2011. PMID: 24516733 Free PMC article. Review.
-
Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.Mult Scler. 2014 Oct;20(11):1541-4. doi: 10.1177/1352458514521888. Epub 2014 Feb 3. Mult Scler. 2014. PMID: 24493474 Free PMC article.
References
-
- Lang HL, Jacobsen H, Ikemizu S, Andersson C, Harlos K, Madsen L, Hjorth P, Sondergaard L, Svejgaard A, Wucherpfennig K, Stuart DI, Bell JI, Jones EY, Fugger L. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol. 2002;3:940–943. doi: 10.1038/ni835. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials